tyrosine kinase jak inhibitors market

Global Tyrosine Kinase JAK Inhibitors Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-03-18
  • Report ID: 70221
  • Pages: 86
  • Format: prudent report format

Snapshot

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Tyrosine Kinase JAK Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tofacitinib
Ruxolitinib
Baricitinib

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Tyrosine Kinase JAK Inhibitors Industry
Figure Tyrosine Kinase JAK Inhibitors Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Tyrosine Kinase JAK Inhibitors
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Tyrosine Kinase JAK Inhibitors
1.2.2 Downstream
Table Application Segment of Tyrosine Kinase JAK Inhibitors
Table Global Tyrosine Kinase JAK Inhibitors Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Tyrosine Kinase JAK Inhibitors Market by Type
3.1 By Type
3.1.1 Tofacitinib
Table Major Company List of Tofacitinib
3.1.2 Ruxolitinib
Table Major Company List of Ruxolitinib
3.1.3 Baricitinib
Table Major Company List of Baricitinib
3.2 Market Size
Table Global Tyrosine Kinase JAK Inhibitors Market 2016-2020, by Type, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2016-2020, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2016-2020, by Type, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2021-2026, by Type, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Pfizer (Company Profile, Sales Data etc.)
4.1.1 Pfizer Profile
Table Pfizer Overview List
4.1.2 Pfizer Products & Services
4.1.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Incyte (Company Profile, Sales Data etc.)
4.2.1 Incyte Profile
Table Incyte Overview List
4.2.2 Incyte Products & Services
4.2.3 Incyte Business Operation Conditions
Table Business Operation of Incyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
4.3.1 Novartis Profile
Table Novartis Overview List
4.3.2 Novartis Products & Services
4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eli Lilly (Company Profile, Sales Data etc.)
4.4.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.4.2 Eli Lilly Products & Services
4.4.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Gilead (Company Profile, Sales Data etc.)
4.5.1 Gilead Profile
Table Gilead Overview List
4.5.2 Gilead Products & Services
4.5.3 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi (Company Profile, Sales Data etc.)
4.6.1 Sanofi Profile
Table Sanofi Overview List
4.6.2 Sanofi Products & Services
4.6.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Galapagos (Company Profile, Sales Data etc.)
4.7.1 Galapagos Profile
Table Galapagos Overview List
4.7.2 Galapagos Products & Services
4.7.3 Galapagos Business Operation Conditions
Table Business Operation of Galapagos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AbbVie (Company Profile, Sales Data etc.)
4.8.1 AbbVie Profile
Table AbbVie Overview List
4.8.2 AbbVie Products & Services
4.8.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Vertex (Company Profile, Sales Data etc.)
4.9.1 Vertex Profile
Table Vertex Overview List
4.9.2 Vertex Products & Services
4.9.3 Vertex Business Operation Conditions
Table Business Operation of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva (Company Profile, Sales Data etc.)
4.10.1 Teva Profile
Table Teva Overview List
4.10.2 Teva Products & Services
4.10.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Astellas Pharma (Company Profile, Sales Data etc.)
4.11.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.11.2 Astellas Pharma Products & Services
4.11.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Celgene (Company Profile, Sales Data etc.)
4.12.1 Celgene Profile
Table Celgene Overview List
4.12.2 Celgene Products & Services
4.12.3 Celgene Business Operation Conditions
Table Business Operation of Celgene (Sales Revenue, Cost, Gross Margin)
4.13 CTI BioPharma (Company Profile, Sales Data etc.)
4.13.1 CTI BioPharma Profile
Table CTI BioPharma Overview List
4.13.2 CTI BioPharma Products & Services
4.13.3 CTI BioPharma Business Operation Conditions
Table Business Operation of CTI BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2016-2020, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue Share in 2020, by Company, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume 2016-2020, by Company, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Tyrosine Kinase JAK Inhibitors Market Concentration, in 2020
Figure Europe Tyrosine Kinase JAK Inhibitors Market Market Concentration, in 2020
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors MMarket Concentration, in 2020
Figure South America Tyrosine Kinase JAK Inhibitors Market Concentration, in 2020
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Rheumatoid Arthritis (RA)
Figure Tyrosine Kinase JAK Inhibitors Demand in Rheumatoid Arthritis (RA), 2016-2020, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Rheumatoid Arthritis (RA), 2016-2020, in Volume
6.1.2 Demand in Polycythemia Vera (PCV)
Figure Tyrosine Kinase JAK Inhibitors Demand in Polycythemia Vera (PCV), 2016-2020, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Polycythemia Vera (PCV), 2016-2020, in Volume
6.1.3 Demand in Myelofibrosis (MF)
Figure Tyrosine Kinase JAK Inhibitors Demand in Myelofibrosis (MF), 2016-2020, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Myelofibrosis (MF), 2016-2020, in Volume
6.1.4 Demand in Others
Figure Tyrosine Kinase JAK Inhibitors Demand in Others, 2016-2020, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2021-2026, by Application, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Market Growth 2021-2026, by Application, in USD Million
Figure Tyrosine Kinase JAK Inhibitors Market Share in 2026, by Application, in USD Million
Table Tyrosine Kinase JAK Inhibitors Demand Forecast 2021-2026, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Growth 2021-2026, by Application, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Tyrosine Kinase JAK Inhibitors Production 2016-2020, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Tyrosine Kinase JAK Inhibitors Market 2016-2020, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2016-2020, by Region, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market 2016-2020, by Region, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in USD Million
Table North America Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Europe Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in USD Million
Table South America Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2021-2026, by Region, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.